As reported in March of 2021, semaglutide, a diabetes weekly shot, helped nondiabetic overweight and obese adults lose a remarkable amount of weight over a period of 68 weeks. There were two groups of people, placebo users, and active drug (semaglutide) users. Neither group knew what they were injecting weekly to remove the "placebo effect".
Wegovy is the newest FDA approved weight loss shot that hit the market in Summer of 2021 that has the most weight loss results than any of its kind. In this blog, Dr. Charles Mok discussed the pros and cons of this weight loss drug and compares it to others on the market.